Compass Pathways Plc (CMPS)
12.00
+0.53
(+4.62%)
USD |
NASDAQ |
Oct 09, 16:00
12.02
+0.02
(+0.17%)
After-Hours: 20:00
Compass Pathways Free Cash Flow : -160.76M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -160.76M |
| March 31, 2026 | -159.63M |
| December 31, 2025 | -157.61M |
| September 30, 2025 | -161.34M |
| June 30, 2025 | -149.05M |
| March 31, 2025 | -144.25M |
| December 31, 2024 | -119.24M |
| September 30, 2024 | -105.63M |
| June 30, 2024 | -101.13M |
| March 31, 2024 | -91.11M |
| December 31, 2023 | -97.82M |
| September 30, 2023 | -115.41M |
| Date | Value |
|---|---|
| June 30, 2023 | -114.49M |
| March 31, 2023 | -108.35M |
| December 31, 2022 | -103.90M |
| September 30, 2022 | -80.81M |
| June 30, 2022 | -77.78M |
| March 31, 2022 | -77.25M |
| December 31, 2021 | -68.07M |
| September 30, 2021 | -62.50M |
| June 30, 2021 | -62.36M |
| March 31, 2021 | -50.90M |
| December 31, 2020 | -41.51M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Silence Therapeutics Plc | -41.79M |
| Biodexa Pharmaceuticals Plc | -10.63M |
| NuCana Plc | -6.612M |
| Mereo BioPharma Group Plc | -25.58M |
| HemoGenyx Pharmaceuticals Plc | -1.937M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -40.37M |
| Cash from Financing (Quarterly) | 8.097M |
| Free Cash Flow Per Share (Quarterly) | -0.2989 |
| Free Cash Flow to Equity (Quarterly) | -41.69M |
| Free Cash Flow to Firm (Quarterly) | -38.90M |
| Free Cash Flow Yield | -11.80% |